Farname Inc. in collaboration with Iranian Society of Gynecology Oncology
Pregnancy-Associated Breast Cancer

Azadeh Joulaee; Nasibeh Khaleghnejad-Tabari

Volume 2, Issue 4 , November and December 2017, Pages 1-3

Abstract
  The majority of cases are very young, less than 40 years old, which means they are out of the screening age range. For older pregnant women, screening is not done both due to possible radiation exposure of fetus and low accuracy of mammographyin pregnancy-induced highly dense breasts. Therefore, all ...  Read More

Retroperitoneal Lymphocele in a Patient with Primary Ovarian Cancer: A Case Report

Leila Mousavi Seresht; Meysam Izadi; Zohreh Yousefi; Amir Hosein Jafarian; Nooshin Babapour; Laya Shirinzadeh; Zahra Rastin

Volume 2, Issue 4 , November and December 2017, Pages 1-3

Abstract
  Introduction: In patients with female genital tract cancers, during treatment, differentiating between a tumor recurrence and a benign phenomenon is of great importance. This study aimed to report a case of retroperitoneal lymphocele in a patient with primary ovarian cancer. Case Presentation: A 49-year-old ...  Read More

Neural Tube Defects: Distribution and Associated Anomalies Diagnosed by Prenatal Ultrasonography in Iranian Fetuses

Behnaz Moradi; Fatemeh Shakki Katouli; Masoumeh Gity; Mohamad Ali Kazemi; Madjid Shakiba; Farzaneh Fattahi Masrour

Volume 2, Issue 4 , November and December 2017, Pages 1-8

Abstract
  Objectives: The current study aimed at providing detailed information about the distribution, associated anomalies, and syndromes in Iranian fetuses with neural tube defects (NTDs). Methods: The current study was conducted in Yas Females’ referral and teaching hospital in 18 months from 2014 to ...  Read More

Recurrence and Fertility Rate in Females with Borderline Ovarian Tumor

Azamsadat Mousavi; Mahshid Shooshtari; Setare Nassiri; Abas Ali Aipour; Setare Akhavan; Narges Zamani

Volume 2, Issue 4 , November and December 2017, Pages 1-5

Abstract
  Background: Currently, the prevalence of borderline ovarian tumors (BOT) is increasing, and given the higher diagnosis in the third and fourth decades of life, fertility sparing procedures are widely used. There are important consequences in females with borderline ovarian tumors and number of effective ...  Read More

Menstrual Adjustment Administering Hormonal Agents: A Survey of Iranian Pilgrim Women During Long-Term Travel

Fakhrolmolouk Yassaee; Reza Shekarriz-Foumani; Shima Sadeghi

Volume 2, Issue 4 , November and December 2017, Pages 1-5

Abstract
  Background: Women’s activity in many social and religious events necessitates them to have their menstruation suppressed, including in yearly Hajj rites for Muslim women. According to the Islamic religious set-ups, Muslim women must be physically and morally clean during the Hajj rites in Mecca. ...  Read More

Prediction of Pre-Eclampsia Development by Placenta Location: A Simple Predictor

Elham Keshavarz; Afarin Sadeghian; Ali Ganjalikhan Hakemi; Fatemeh Talei Khtibi

Volume 2, Issue 4 , November and December 2017, Pages 1-5

Abstract
  Background: Pre-eclampsia complicates 5% to 8% of all pregnancies and annual incidence of pre-eclampsia is about 5% of all pregnancies around the world and is a significant cause of both maternal and fetal mortality and morbidity if left untreated. Objectives: According to previous studies, blood supply ...  Read More

Intraperitoneal Chemotherapy in Ovarian Cancer

Setareh Akhavan; Nadereh Behtash; Mohsen Esfandbod; Mitra Moddares Gilani; Azam-Sadat Mousavi; Shahrzad Sheikh Hasani

Volume 2, Issue 4 , November and December 2017, Pages 1-4

Abstract
  Epithelial ovarian cancer (EOC) is the fifth leading cause of cancer death in women. Primary surgery, followed by adjuvant chemotherapy is the basis of treatment for this disease. A standard treatment includes primary surgery and if possible optimal debulking surgery (tumor residue of <; 1 cm), followed ...  Read More